https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-04-09 / Med Oncol 2024 Apr;41(5):112
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-04-09 / Med Oncol 2024 Apr;41(5):1122024-04-09 00:00:002024-04-09 00:00:00Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-03-21 / Front Immunol 2024;15:1375433
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-03-21 / Front Immunol 2024;15:13754332024-03-21 00:00:002024-03-21 00:00:00New hopes for the breast cancer treatment: perspectives on the oncolytic virus therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-02-01 / Cancer Lett 2024 Mar;585:216634
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-02-01 / Cancer Lett 2024 Mar;585:2166342024-02-01 00:00:002024-02-01 00:00:00Oncolytic virus-based combination therapy in breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-12-26 / Mol Aspects Med 2024 Feb;95:101239
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-12-26 / Mol Aspects Med 2024 Feb;95:1012392023-12-26 00:00:002024-01-30 12:49:47Reviewing the significance of dendritic cell vaccines in interrupting breast cancer development
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-09-01 / Clin Exp Med 2023 Dec;23(8):4431-4447
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-09-01 / Clin Exp Med 2023 Dec;23(8):4431-44472023-09-01 00:00:002023-09-01 00:00:00Breast cancer immunotherapy: a comprehensive review
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-07-15 / J Immunol 2023 Jul;211(2):219-228
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-07-15 / J Immunol 2023 Jul;211(2):219-2282023-07-15 00:00:002024-01-16 09:10:27Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-04-12 / Biomed Pharmacother 2023 Jun;162:114685
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-04-12 / Biomed Pharmacother 2023 Jun;162:1146852023-04-12 00:00:002023-04-12 00:00:00Dendritic cell vaccines in breast cancer: Immune modulation and immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-02-17 / J Breast Cancer 2023 Apr;26(2):186-200
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-02-17 / J Breast Cancer 2023 Apr;26(2):186-2002023-02-17 00:00:002023-02-17 00:00:00Inhibition of Tumor Growth and Metastasis by Newcastle Disease Virus Strain P05 in a Breast Cancer Mouse Model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-02-13 / NPJ Breast Cancer 2023 Feb;9(1):7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-02-13 / NPJ Breast Cancer 2023 Feb;9(1):72023-02-13 00:00:002023-02-13 00:00:00Immunotherapy in breast cancer: an overview of current strategies and perspectives
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-01-17 / Biomedicines 2023 Jan;11(2)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-01-17 / Biomedicines 2023 Jan;11(2)2023-01-17 00:00:002023-01-17 00:00:00Modification of Breast Cancer Milieu with Chemotherapy plus Dendritic Cell Vaccine: An Approach to Select Best Therapeutic Strategies
